For example, it has been shown that alteration frequency of typical PC mutations (i.e., AR, PTEN, RB1, ATM, CDK12, among others) progressively increases from locoregional disease to metastatic-non-castrate to castrate-resistant PC. This evidence concerns the gene PTEN and pachyonychia congenita.